Posts

Iovance submits lifileucel BLA to US FDA

Iovance is pursuing accelerated approval in advanced melanoma for the tumour inf...

Novel drug approvals declined in 2022 but what are the ...

Faced with such a disappointing approval number last year, manufacturers hope fo...

National Resilience secures funding for domestic bioman...

National Resilience expects the expanded capacity will help in securing the supp...

Regenerative medicine: new focus on VEGF target?

According to GlobalData’s Drugs database, early-stage therapies are focused on v...

US FDA approves Pharming’s Joenja to treat APDS

Joenja’s approval was based on the data obtained from a Phase II/III clinical tr...

STAT+: Former surgeon general Jerome Adams tries to out...

Former surgeon general Jerome Adams has emerged as a leading voice on public hea...

Is early rhythm control in atrial fibrillation care cos...

Sophia Antipolis, 27 March 2023:  Patients with atrial fibrillation (AF) benefit...

“Glassiness” and “blurriness” might explain the behavio...

Tokyo, Japan – Researchers from Tokyo Metropolitan University have uncovered clu...

What do the elements sound like? (video)

INDIANAPOLIS, March 26, 2023 — In chemistry, we have He, Fe and Ca — but what ab...

Colorful films could help buildings, cars keep their cool

INDIANAPOLIS, March 26, 2023 — The cold blast of an air conditioner can be a wel...

Cancer cells with thicker glycocalyx barrier are better...

One of the ways that cancer cells hide from the body’s immune system is by formi...

New ways to measure curls and kinks could make it easie...

INDIANAPOLIS, March 26, 2023 — Black women and others with curly or kinky hair e...

Scientists make critical progress toward preventing C. ...

Each year, about 500,000 people in the U.S. deal with gastrointestinal infection...

Embryos’ development is delayed in pregnancies that end...

Embryos in pregnancies that end in miscarriage take longer to develop in the wom...

‘Nano inks’ could passively control temperature in buil...

World-first ‘phase change inks’ that could transform how we heat and cool buildi...

China’s NMPA grants conditional approval for AstraZenec...

Calquence’s conditional approval was based on the data from the Phase II ACE-LY-...